About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Alliance to Control Diabetes | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT02193984

Alliance to Control Diabetes

Alliance to Control Diabetes was a 2.5-year study funded by the American Academy of Family Physicians Foundation. The study was designed to help patients better manage their diabetes, and was a partne...

Lead sponsor: San Diego State University•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

San Diego State University

Collaborators

Peers for Progress
American Academy of Family Physicians

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Must be at least 18 years old
•Must be diagnosed with Diabetes Mellitus Type I, Diabetes Mellitus Type II or Gestational Diabetes
•Must be a resident of Imperial County
•Must be a current patient of Clínicas de Salud del Pueblo, Inc., at one of the three participating clinics
•Must speak Spanish and/or English
•Must plan on remaining in Imperial County for at least 12 months after enrollment into the study

Exclusion Criteria

•Must not be involved in any other diabetes-related study

Related studies

RECRUITINGPhase 4

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

NCT06613854 · Type 2 Diabetes Mellitus (T2DM)

RECRUITINGPhase 1

Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes

NCT07535307 · Diabetes Mellitus

RECRUITINGPhase 2

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07224321 · Type 1 Diabetes Mellitus

RECRUITINGPhase 4

Glycemic Control With Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin Combination

NCT06862739 · Diabetes Mellitus, Type 2 DM

Measurement of Ocular Blood Flow and Retinal Oxygen Extraction in Diabetic Patients

NCT07536516 · Diabetes Mellitus

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 13, 2017Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment336

Start dateFeb 2009

Last updatedJan 13, 2017

Condition

Diabetes Mellitus

Locations shown

San Diego State University Research Foundation

Calexico, California

San Diego State University Research Foundation

San Diego, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 13, 2017Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions